BSECompany Update6 Oct 2026 · 6 Oct 2026, 02:30 pm

Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.

Novelix Pharmaceuticals Ltd · 536565

✦ AI Summary

Novelix Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September, 2026, confirming the dematerialization of securities and updating the records of the company.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novelix Pharmaceuticals Ltd - 536565 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

446a887c-7ead-4eef-b47e-30d5c8fa18ed.pdf

pdf

Download →
View document text
Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) Date: 06th October, 2026 The Deputy Manager (Department of Corporate Services), BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. Sub.: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Ref.: Scrip Id: NOVELIX Scrip Code: 536565 Respected Sir/Madam, With reference to above, we are enclosing herewith the Certificate from our Registrar and Share Transfer Agent (R&T Agent) – i.e. M/s. Venture Capital and Corporate Investments Private Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for Novelix Pharmaceuticals Limited for the quarter ended 30th September, 2026. Please take the same on your records. Thanking you, Yours Faithfully, For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com Date: 05-10-2026 THE COMPANY SECRETARY NOVELIX PHARMACEUTICALS LIMITED REGD. OFF: # 3-6-237/610, FLAT NO: 610, 6TH FLOOR LINGAPUR LA BUILDERS, ALSO KNOWN AS AMRUTHA ESTATES HIMAYAT NAGAR, HYDERABAD, TELANGANA- 500029 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.09.2026 Ref: Security Code – 536565 ISIN: INE314I01036 We hereby certify that the securities received for dematerialisation have been mutilated and cancelled after due verification and the name of the depositories (National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) has been updated in the records of company as the registered owner within 15 days of receipt of valid DRF & Share certificate of said company and the details of securities are furnished to the stock exchange(s). We request you to take this information on record and to inform Depositories(s) and Stock Exchange(s) wherever your securities are listed accordingly. Thanking you, Yours faithfully, for Venture Capital and Corporate Investments Private Limited. Authorised Signatory. Note : You are requested to inform Depositories(s) and Stock Exchange(s) wherever your security is listed accordingly.